CTRL and neoplasm: However, EC-siMYC nanoparticles effectively normalized tumor vessels, as shown by reduced hypoxia, increased mural cell coverage and enhanced vessel perfusion in both RBPj∆E and Ctrl mice, and decreased vessel density and necrosis in RBPj∆E mice (Figure 5E-L, Figure S6D).